Miltenyi Biotec B.V. & Co. KG Capacity Update April 2025: Cell & Gene Therapy

The significant costs for manufacturing cell & gene therapies continue to create a major barrier to bringing these transformative medicines to patients in need. Miltenyi Bioindustry, the CDMO from Miltenyi Biotec, uses Miltenyi products to offer automated and closed solutions for cell therapy processes.

In this presentation, Shaan Gareeb highlights the capabilities of our Cell Therapy Center of Excellence in San Jose, California, one of five global Miltenyi Bioindustry sites. Our San Jose facility is built for purpose with three ballroom-style suites fitted with 26 prodigies capable of a total of over 1000 batches per year (based on a seven-day process).

Discover how Miltenyi Bioindustry’s unique approach to cell therapy development and manufacturing can enable scalable, flexible, and low-cost manufacturing solutions.